암 온열요법 시장(2026-2030년)

The global hyperthermia cancer treatment market is forecasted to grow by USD 70992.2 thousand during 2025-2030, accelerating at a CAGR of 6.3% during the forecast period. The report on the global hyperthermia cancer treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global cancer incidence rates, technological advancements in equipment, expansion of clinical research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global hyperthermia cancer treatment market is segmented as below:

By End-User

• Hospitals and specialty clinics
• Ambulatory surgical centers
• Research institutes

By Device

• Radiofrequency hyperthermia devices
• Microwave hyperthermia devices
• Infrared radiation hyperthermia devices
• Ultrasound based hyperthermia devices

By Application

• Breast cancer
• Liver cancer
• Soft tissue sarcoma
• Leukemia
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the adoption of nanoparticle mediated hyperthermia as one of the prime reasons driving the global hyperthermia cancer treatment market growth during the next few years. Also, expansion of ambulatory cancer centers and ai in treatment planning will lead to sizable demand in the market.

The report on the global hyperthermia cancer treatment market covers the following areas:

• Global hyperthermia cancer treatment market sizing
• Global hyperthermia cancer treatment market forecast
• Global hyperthermia cancer treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global hyperthermia cancer treatment market vendors that include Alba Hyperthermia, Belmont Medical Tech., Celsius42 GmbH, Daeyang Medical, DSMED, EDAP TMS, Gamida, Haifu Medical Technology, HECKEL Medizintechnik GmbH, Hydrosun Medizintechnik GmbH, Hypertherm Medical, Koninklijke Philips NV, Medtronic Plc, New Phase, ONCOTHERM KFT, Pyrexar Medical, RanD SpA, Therma Solutions, Vinita Co. Ltd., VON ARDENNE BIOMEDICAL GmbH. Also, the global hyperthermia cancer treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Device
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Hyperthermia Cancer Treatment Market 2020 - 2024
  • Historic Market Size - Data Table on Global Hyperthermia Cancer Treatment Market 2020 - 2024 ($ thousand)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.3 Device segment analysis 2020 - 2024
  • Historic Market Size - Device Segment 2020 - 2024 ($ thousand)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Hyperthermia Cancer Treatment Market
• 6.2 Impact of geopolitical conflicts on Global Hyperthermia Cancer Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals and specialty clinics - Market size and forecast 2025-2030
• 8.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 8.5 Research institutes - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

9 Market Segmentation by Device

• 9.1 Market segments
• 9.2 Comparison by Device
• 9.3 Radiofrequency hyperthermia devices - Market size and forecast 2025-2030
• 9.4 Microwave hyperthermia devices - Market size and forecast 2025-2030
• 9.5 Infrared radiation hyperthermia devices - Market size and forecast 2025-2030
• 9.6 Ultrasound based hyperthermia devices - Market size and forecast 2025-2030
• 9.7 Market opportunity by Device
  • Market opportunity by Device ($ thousand)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Breast cancer - Market size and forecast 2025-2030
• 10.4 Liver cancer - Market size and forecast 2025-2030
• 10.5 Soft tissue sarcoma - Market size and forecast 2025-2030
• 10.6 Leukemia - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Application
  • Market opportunity by Application ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global cancer incidence rates
  • Technological advancements in equipment
  • Expansion of clinical research
• 13.2 Market challenges
  • Technical limitations in thermal dosimetry
  • Stringent regulatory approval pathways
  • Restricted reimbursement and high costs
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Adoption of nanoparticle mediated hyperthermia
  • Expansion of ambulatory cancer centers
  • AI In Treatment Planning

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Belmont Medical Tech.
  • Belmont Medical Tech. - Overview
  • Belmont Medical Tech. - Product / Service
  • Belmont Medical Tech. - Key offerings
  • SWOT
• 15.5 Daeyang Medical
  • Daeyang Medical - Overview
  • Daeyang Medical - Product / Service
  • Daeyang Medical - Key offerings
  • SWOT
• 15.6 DSMED
  • DSMED - Overview
  • DSMED - Product / Service
  • DSMED - Key offerings
  • SWOT
• 15.7 EDAP TMS
  • EDAP TMS - Overview
  • EDAP TMS - Product / Service
  • EDAP TMS - Key offerings
  • SWOT
• 15.8 Haifu Medical Technology
  • Haifu Medical Technology - Overview
  • Haifu Medical Technology - Product / Service
  • Haifu Medical Technology - Key offerings
  • SWOT
• 15.9 HECKEL Medizintechnik GmbH
  • HECKEL Medizintechnik GmbH - Overview
  • HECKEL Medizintechnik GmbH - Product / Service
  • HECKEL Medizintechnik GmbH - Key offerings
  • SWOT
• 15.10 Hydrosun Medizintechnik GmbH
  • Hydrosun Medizintechnik GmbH - Overview
  • Hydrosun Medizintechnik GmbH - Product / Service
  • Hydrosun Medizintechnik GmbH - Key offerings
  • SWOT
• 15.11 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.12 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.13 New Phase
  • New Phase - Overview
  • New Phase - Product / Service
  • New Phase - Key offerings
  • SWOT
• 15.14 Pyrexar Medical
  • Pyrexar Medical - Overview
  • Pyrexar Medical - Product / Service
  • Pyrexar Medical - Key offerings
  • SWOT
• 15.15 RanD SpA
  • RanD SpA - Overview
  • RanD SpA - Product / Service
  • RanD SpA - Key offerings
  • SWOT
• 15.16 Therma Solutions
  • Therma Solutions - Overview
  • Therma Solutions - Product / Service
  • Therma Solutions - Key offerings
  • SWOT
• 15.17 Vinita Co. Ltd.
  • Vinita Co. Ltd. - Overview
  • Vinita Co. Ltd. - Product / Service
  • Vinita Co. Ltd. - Key offerings
  • SWOT
• 15.18 VON ARDENNE BIOMEDICAL GmbH
  • VON ARDENNE BIOMEDICAL GmbH - Overview
  • VON ARDENNE BIOMEDICAL GmbH - Product / Service
  • VON ARDENNE BIOMEDICAL GmbH - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations